|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
28 November 2022 |
|
Main ID: |
NCT03447210 |
|
Date of registration:
|
21/02/2018 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Study of HIV, HCV, APS and Phylogenetics for PWID
SHARP |
|
Scientific title:
|
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention |
|
Date of first enrolment:
|
February 26, 2018 |
|
Target sample size:
|
4301 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03447210 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Kenya
| | | | | | | |
|
Contacts
|
|
Name:
|
Joshua Herbeck, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Washington |
|
|
Name:
|
Carey Farquhar, MD, MPH |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Washington |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- > or = 18 years of age
- Active intravenous drug use (IDU) as defined by injecting at least twice in the past
month
- Willing and able to provide informed consent
- HIV infected (either new diagnosis or known diagnosis)
- Willing and able to provide locator information for sexual and/or injecting partners
Exclusion Criteria:
• Classified as at high risk for IPV*
*Participants will be classified as at moderate risk for IPV if they report 1) history of
IPV during their lifetime either from a current or past partner; and/or 2) fear of IPV if
they participate in the study.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
HIV/AIDS
|
|
Hepatitis C
|
|
Intervention(s)
|
|
Behavioral: Assisted Partner Services
|
|
Primary Outcome(s)
|
|
Injecting partners tested
[Time Frame: 4 years]
|
|
Index participants linked to HIV and HCV care
[Time Frame: 4 years]
|
|
Partners diagnosed with HIV and HCV
[Time Frame: 4 years]
|
|
HCV-infected partners linked to HCV care
[Time Frame: 4 years]
|
|
Sexual partners tested
[Time Frame: 4 years]
|
|
HIV-infected partners linked to HIV care
[Time Frame: 4 years]
|
|
Secondary ID(s)
|
|
STUDY00001536
|
|
R01DA043409
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|